| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 41, 260-265, Copyright © 1975 by Endocrine Society
ARTICLES |
JM Falko, SE Crockett,, S Cataland and EL Mazzaferri
Ten normal volunteers ingested emulsified corn oil and the immunoreactive GIP, insulin (IRI) and nonesterified fatty acid (NEFA) responses were measured. Serum GIP levels increased after the ingestion of corn oil in all subjects, rising from a mean fasting level of 272 pg/ml to 856 +/- 272 pg/ml (P less than 0.05) by 30 minutes. The peak mean serum GIP concentration of 1,345 +/- 291 pg/ml occurred at 60 minutes; and mean serum GIP levels at 180 minutes remained significantly elevated over fasting values. Serum IRI, glucose and NEFA concentrations did not change during the 180 minutes of study. No changes in serum GIP concentrations occurred when, for control purposes, six volunteers ingested water on another day. We conclude: 1) Fat is a potent stimulus for the release of GIP in normal individuals. 2) Endogenously released GIP is not insulinotropic under the conditions of this study.
This article has been cited by other articles:
![]() |
M. C. Althage, E. L. Ford, S. Wang, P. Tso, K. S. Polonsky, and B. M. Wice Targeted Ablation of Glucose-dependent Insulinotropic Polypeptide-producing Cells in Transgenic Mice Reduces Obesity and Insulin Resistance Induced by a High Fat Diet J. Biol. Chem., June 27, 2008; 283(26): 18365 - 18376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salehi, B. A. Aulinger, and D. A. D'Alessio Targeting {beta}-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins Endocr. Rev., May 1, 2008; 29(3): 367 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lu, Q. Yang, W. Sun, S. C. Woods, D. D'Alessio, and P. Tso Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1130 - G1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. McClean, N. Irwin, R. S. Cassidy, J. J. Holst, V. A. Gault, and P. R. Flatt GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1746 - E1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Ding, Q. Zhong, and C. M. Isales Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1 Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E390 - E396. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Wang, M. M.-Y. Chi, L. Li, K. H. Moley, and B. M. Wice Studies with GIP/Ins cells indicate secretion by gut K cells is KATP channel independent Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E988 - E1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ehses, S. S. T. Lee, R. A. Pederson, and C. H. S. McIntosh A New Pathway for Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Signaling. EVIDENCE FOR THE INVOLVEMENT OF PHOSPHOLIPASE A2 IN GIP-STIMULATED INSULIN SECRETION J. Biol. Chem., June 22, 2001; 276(26): 23667 - 23673. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |